FUROSEMIDE

Product NDC: 36000-283
11-digit product format: 360000283
Labeler code: 36000
Product ID: 36000-283_b4c1ae97-0f6c-4ae1-858a-4e0ab8f1ce53
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: furosemide
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Labeler: Baxter Healthcare Corporation
Application: ANDA202747
Marketing category: ANDA
Marketing start: 2014-02-06
Substance: FUROSEMIDE
Active strength: 10 mg/mL
Pharmacologic classes: Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A202747-001	FUROSEMIDE	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A202747-001	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A202747-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	RS	2014-01-27	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A202747-001	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202747-001	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202747-001	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202747-001	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202747-001	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202747-001	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202747-001	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202747-001	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202747-001	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A202747-001	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202747-001	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202747-001	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202747-001	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A202747-001	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202747-001	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A202747-001	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A202747-001	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A202747-001	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A202747-001	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A202747-001	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A202747-001	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A202747-001	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A202747-001	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A202747-001	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A202747-001	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A202747-001	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A202747-001	AP	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A202747-001	AP	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A202747-001	AP	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A202747-001	AP	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A202747-001	AP	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A202747-001	AP	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A202747-001	AP	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A202747-001	AP	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A202747-001	AP	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A202747-001	AP	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A202747-001	AP	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A202747-001	AP	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A202747-001	AP	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A202747-001	AP	1	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: FUROSEMIDE
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
FUROSEMIDE	10 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
7LXU5N7ZO5	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1719286	Internal RxNorm lookup
1719290	Internal RxNorm lookup
1719291	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
c71371a7-75c5-45b8-b762-8d782d4c71bc	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d80d3aff-3a63-4d7b-a2be-fd9388b04330	Product name	9	20250806
9061e89f-9c86-4196-b34b-886fc1673cc4	Product name	1	20140821

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
36000-283-25	FUROSEMIDE	25 in 1 BOX	INJECTION, SOLUTION	25		23
36000-283-25	FUROSEMIDE	4 mL in 1 VIAL, SINGLE-DOSE	INJECTION, SOLUTION	4		23

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
36000-283-25	ML - Milliliter	36000-283	499969b8-4f07-45ac-be6e-1fd7890fa695	1	2014-08-01

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
FUROSEMIDE	ACTIVE INGREDIENT	7LXU5N7ZO5	FUROSEMIDE INJECTION, SOLUTION [CLARIS LIFESCIENCES, INC]	8
FUROSEMIDE	ACTIVE MOIETY	7LXU5N7ZO5	FUROSEMIDE INJECTION, SOLUTION [CLARIS LIFESCIENCES, INC]	8
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	FUROSEMIDE INJECTION, SOLUTION [CLARIS LIFESCIENCES, INC]	8
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	FUROSEMIDE INJECTION, SOLUTION [CLARIS LIFESCIENCES, INC]	8
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	FUROSEMIDE INJECTION, SOLUTION [CLARIS LIFESCIENCES, INC]	8
WATER	INACTIVE INGREDIENT	059QF0KO0R	FUROSEMIDE INJECTION, SOLUTION [CLARIS LIFESCIENCES, INC]	8

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
36000-283	FUROSEMIDE INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION]	21	Current NDC, Legacy NDC, 2 package rows	20240921_c71371a7-75c5-45b8-b762-8d782d4c71bc.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
FUROSEMIDE	FUROSEMIDE	Cardinal Health 107, LLC	2590ebb6-ce2a-4e23-9244-e54e3010d488	2026-01-15	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202747 application number: ANDA202747
FUROSEMIDE	FUROSEMIDE	Civica, Inc.	7ecaa5af-d186-4380-b105-e7e528f75cc7	2025-11-12	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202747 application number: ANDA202747
FUROSEMIDE	FUROSEMIDE	Henry Schein, Inc.	a9853417-0442-4f53-9543-e0749bc3c80d	2025-10-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202747 application number: ANDA202747
Furosemide	FUROSEMIDE	Henry Schein, Inc.	d8407b0e-7838-4ab6-b9dd-1f7ecf1e0a17	2025-10-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202747 application number: ANDA202747
FUROSEMIDE	FUROSEMIDE	REMEDYREPACK INC.	ab1a7e16-f746-41af-8faf-b69d3ffd62ba	2025-08-15	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202747 application number: ANDA202747
FUROSEMIDE	FUROSEMIDE	Baxter Healthcare Corporation	c71371a7-75c5-45b8-b762-8d782d4c71bc	2025-06-30	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202747 application number: ANDA202747 ndc (product): 36000-283
FUROSEMIDE	FUROSEMIDE	Medical Purchasing Solutions, LLC	6a2235e8-d488-2d43-e053-2991aa0aa485	2023-05-30	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202747 application number: ANDA202747
FUROSEMIDE	FUROSEMIDE	Medical Purchasing Solutions, LLC	6947af02-f50b-7f9c-e053-2a91aa0a45cd	2023-05-22	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202747 application number: ANDA202747

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
7LXU5N7ZO5	FUROSEMIDE	54-31-9	FUROSEMIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1719286	furosemide 100 MG in 10 ML Injection	PSN	c71371a7-75c5-45b8-b762-8d782d4c71bc	23
1719290	furosemide 20 MG in 2 ML Injection	PSN	c71371a7-75c5-45b8-b762-8d782d4c71bc	23
1719291	furosemide 40 MG in 4 ML Injection	PSN	c71371a7-75c5-45b8-b762-8d782d4c71bc	23
1719286	10 ML furosemide 10 MG/ML Injection	SCD	c71371a7-75c5-45b8-b762-8d782d4c71bc	23
1719290	2 ML furosemide 10 MG/ML Injection	SCD	c71371a7-75c5-45b8-b762-8d782d4c71bc	23
1719291	4 ML furosemide 10 MG/ML Injection	SCD	c71371a7-75c5-45b8-b762-8d782d4c71bc	23
1719286	furosemide 100 MG per 10 ML Injection	SY	c71371a7-75c5-45b8-b762-8d782d4c71bc	23
1719290	furosemide 20 MG per 2 ML Injection	SY	c71371a7-75c5-45b8-b762-8d782d4c71bc	23
1719291	furosemide 40 MG per 4 ML Injection	SY	c71371a7-75c5-45b8-b762-8d782d4c71bc	23
1719291	furosemide 40 MG in 4 ML Injection	PSN	2590ebb6-ce2a-4e23-9244-e54e3010d488	8
1719291	4 ML furosemide 10 MG/ML Injection	SCD	2590ebb6-ce2a-4e23-9244-e54e3010d488	8
1719291	furosemide 40 MG per 4 ML Injection	SY	2590ebb6-ce2a-4e23-9244-e54e3010d488	8
1719291	furosemide 40 MG in 4 ML Injection	PSN	d8407b0e-7838-4ab6-b9dd-1f7ecf1e0a17	5
1719291	4 ML furosemide 10 MG/ML Injection	SCD	d8407b0e-7838-4ab6-b9dd-1f7ecf1e0a17	5
1719291	furosemide 40 MG per 4 ML Injection	SY	d8407b0e-7838-4ab6-b9dd-1f7ecf1e0a17	5
1719291	furosemide 40 MG in 4 ML Injection	PSN	6947af02-f50b-7f9c-e053-2a91aa0a45cd	3
1719291	4 ML furosemide 10 MG/ML Injection	SCD	6947af02-f50b-7f9c-e053-2a91aa0a45cd	3
1719291	furosemide 40 MG per 4 ML Injection	SY	6947af02-f50b-7f9c-e053-2a91aa0a45cd	3
1719291	furosemide 40 MG in 4 ML Injection	PSN	ab1a7e16-f746-41af-8faf-b69d3ffd62ba	1
1719291	4 ML furosemide 10 MG/ML Injection	SCD	ab1a7e16-f746-41af-8faf-b69d3ffd62ba	1
1719291	furosemide 40 MG per 4 ML Injection	SY	ab1a7e16-f746-41af-8faf-b69d3ffd62ba	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
36000-283-25	36000028325	25 VIAL, SINGLE-DOSE in 1 BOX (36000-283-25) / 4 mL in 1 VIAL, SINGLE-DOSE	2014-02-06	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
FUROSEMIDE INJECTION, USP 10 mg/mL	Cardinal Health 107, LLC	2026-01-15	HUMAN PRESCRIPTION DRUG LABEL	8
Furosemide	Henry Schein, Inc.	2025-10-31	HUMAN PRESCRIPTION DRUG LABEL	5
FUROSEMIDE INJECTION, USP 10 mg/mL	REMEDYREPACK INC.	2025-08-15	HUMAN PRESCRIPTION DRUG LABEL	1
FUROSEMIDE INJECTION, USP 10 mg/mL	Baxter Healthcare Corporation \| BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED	2025-06-30	HUMAN PRESCRIPTION DRUG LABEL	23
FUROSEMIDE INJECTION, USP 10 mg/mL	Medical Purchasing Solutions, LLC	2023-05-22	HUMAN PRESCRIPTION DRUG LABEL	3
Furosemide	General Injectables and Vaccines, Inc.	2022-12-21	HUMAN PRESCRIPTION DRUG LABEL	4
Model AA-8565CV-ACT Model AA-8565CV	Aerospace Accessory Service, Inc	2021-05-18	MEDICAL DEVICE	3